Real-World Data Highlight the Benefits of Thrombectomy for Pulmonary Embolism Patients
3 Articles
3 Articles
STORM-PE subset analysis demonstrates correlation between clinical assessments and real-world functional recovery
Penumbra has announced results from a subset analysis of the STORM-PE randomised controlled trial (RCT), which, according to the company, is the first trial to demonstrate a significant correlation between real-world, daily step-based activity as captured on a consumer wearable device and patient performance in the clinical six-minute-walk test. The findings were presented at this […]
STORM-PE and STRIKE-PE Data Presented for Penumbra’s CAVT for Pulmonary Embolism
October 6, 2026—Penumbra, Inc., announced new STORM-PE findings examining the relationship between activity recorded by wearable devices and clinic-based assessments of functional recovery after pulmonary embolism (PE). The subset analysis of the randomized controlled trial (RCT) was presented at the Vascular Interventional Advances (VIVA) 2026 conference. According to Penumbra, the prospective, multicenter, pivotal STORM-PE RCT enrolled 100 pat…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium






